BCL11A is a repressor of the fetal hemoglobin gene. Therefore, researchers created a [ Select ] ["LOF", "GOF"] mutation to [ Select ] ["repress", "induce"] expression of fetal hemoglobin. To create this mutation in BCL11A, researchers used CRISPR/Cas9 to change the [ Select ] ["coding region", "enhancer", "promoter", "5'UTR"] for BCL11A.
Flag question: Question 5
Question 51 pts
The easiest way to create the mutation described above using CRISPR/Cas9 is to use the cell's:
Group of answer choices
HDR pathway
NHEJ pathway